Martha Demski

Direttore/Membro del Consiglio presso CHIMERIX, INC.

Patrimonio netto: 140 576 $ in data 31/05/2024

71 anni

100 relazioni

Health Technology

Consumer Services

Finance

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Bruce Steel	M	57	EQUILLIUM, INC.	7 anni
Daniel Bradbury	M	62	EQUILLIUM, INC.	7 anni
Michael Andriole	M	51	CHIMERIX, INC.	5 anni
Ted Davis	M	66	ALPHA TEKNOVA, INC.	28 anni
Jack Khattar	M	62	ADAMAS PHARMACEUTICALS, INC.	3 anni
Michael Sherman	M	58	CHIMERIX, INC.	5 anni
Stephen Connelly	M	42	EQUILLIUM, INC.	7 anni
Michelle LaSpaluto	F	50	CHIMERIX, INC.	13 anni
Stephen Gunstream	M	45	ALPHA TEKNOVA, INC.	4 anni
Damon Terrill	M	54	ALPHA TEKNOVA, INC.	4 anni
Roy W. Ware	M	-	CHIMERIX, INC.	17 anni
Bala S. Manian	M	78	EQUILLIUM, INC.	7 anni
Matthew Lowell	M	53	ALPHA TEKNOVA, INC.	3 anni
Charles McDermott	M	52	EQUILLIUM, INC.	6 anni
Alexander Vos	M	61	ALPHA TEKNOVA, INC.	3 anni
Victoria Vakiener	F	60	CHIMERIX, INC.	3 anni
Michael Alrutz	M	54	CHIMERIX, INC.	12 anni
Jennifer Henry	F	-	ALPHA TEKNOVA, INC.	3 anni
Pratik Multani	M	57	CHIMERIX, INC.	4 anni
Robert Meyer	M	65	CHIMERIX, INC.	6 anni
Mark Pruzanski	M	56	EQUILLIUM, INC.	6 anni
Lisa Decker	M	55	CHIMERIX, INC.	1 anni
Michael Moore	M	-	EQUILLIUM, INC.	4 anni
Yu Katherine Xu	M	52	EQUILLIUM, INC.	3 anni
Fred Middleton	M	74	CHIMERIX, INC.	6 anni
Brett Robertson	F	64	ALPHA TEKNOVA, INC.	3 anni
Barbara Troupin	M	56	EQUILLIUM, INC.	2 anni
David Jakeman	M	47	CHIMERIX, INC.	15 anni
Matthew MacKowski	M	69	ALPHA TEKNOVA, INC.	5 anni
Maple Fung	M	-	EQUILLIUM, INC.	4 anni
Allen Melemed	M	60	CHIMERIX, INC.	4 anni
Caryn Barnett	F	-	CHIMERIX, INC.	4 anni
Michael Goldstein	M	-	ADMA BIOLOGICS, INC.	3 anni
Irene Davis	F	64	ALPHA TEKNOVA, INC.	9 anni
Christopher L. Jordan	M	-	CHIMERIX, INC.	2 anni
Ron LeTendre	M	-	ALPHA TEKNOVA, INC.	4 anni
Odin Naderer	M	-	CHIMERIX, INC.	10 anni
Cherie Ng	F	-	EQUILLIUM, INC.	-
Bryan A. Roecklein	M	-	ADAMAS PHARMACEUTICALS, INC.	3 anni
Joshua Allen	M	-	CHIMERIX, INC.	3 anni
Harjit Kullar	M	-	ALPHA TEKNOVA, INC.	4 anni
Thomas Riga	M	48	CHIMERIX, INC.	1 anni
Christine Zedelmayer	F	54	EQUILLIUM, INC.	6 anni
Young Kwon	M	52	ADMA BIOLOGICS, INC.	3 anni
Matthew R. Ritter	M	-	EQUILLIUM, INC.	-
Alexander Herzick	M	44	ALPHA TEKNOVA, INC.	5 anni
Joel Rothman	M	55	EQUILLIUM, INC.	6 anni
Paul Grossman	M	63	ALPHA TEKNOVA, INC.	5 anni
Cindy Petersen	F	-	ADMA BIOLOGICS, INC.	2 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
George R. Painter	M	-	CHIMERIX, INC.	12 anni
Gregory T. Went	M	60	ADAMAS PHARMACEUTICALS, INC.	19 anni
Timothy J. Wollaeger	M	80	CHIMERIX, INC.	16 anni
Kenneth Moch	M	69	CHIMERIX, INC.	5 anni
Vijay Samant	M	77	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	19 anni
George W. Mahaffey	M	65	Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	5 anni
François Ferré	M	66	Ajinomoto Althea, Inc. Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA.	15 anni
John Dobak	M	58	Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	7 anni
Alan Rappaport	M	71	US Trust	-
Seth A. Rudnick	M	75	CHIMERIX, INC.	-
James Niedel	M	79	CHIMERIX, INC.	7 anni
David Mahoney	M	69	ADAMAS PHARMACEUTICALS, INC.	12 anni
Jennifer J. Rhodes	F	53	ADAMAS PHARMACEUTICALS, INC.	-
M. Berrey	M	57	CHIMERIX, INC.	7 anni
Keith D. Hall	M	62	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	15 anni
Wende Hutton	F	63	CHIMERIX, INC.	-
Dolca Thomas	M	53	EQUILLIUM, INC.	1 anni
Timothy Trost	M	66	CHIMERIX, INC.	7 anni
John Leonard	M	66	CHIMERIX, INC.	4 anni
Christopher B. Prentiss	M	49	ADAMAS PHARMACEUTICALS, INC.	6 anni
Alan R. Engbring	M	-	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	17 anni
Robert McNamara	M	67	ALPHA TEKNOVA, INC.	2 anni
Larry Smith	M	63	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	16 anni
Edward F. Greissing	M	73	CHIMERIX, INC.	3 anni
Hervé Momméja-Marin	M	53	CHIMERIX, INC.	-
Grace U. Shin	F	59	ADAMAS PHARMACEUTICALS, INC.	-
Alfred G. Merriweather	M	70	ADAMAS PHARMACEUTICALS, INC.	2 anni
Mardi Dier	F	60	ADAMAS PHARMACEUTICALS, INC.	4 anni
Ashleigh Barreto	F	-	ADAMAS PHARMACEUTICALS, INC.	-
Bob H. Campbell	M	86	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	10 anni
Robert C. Merton	M	79	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	17 anni
Gary Lyons	M	73	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	22 anni
Joseph T. Schepers	M	65	CHIMERIX, INC.	3 anni
Daniel Janney	M	58	Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	8 anni
Clarence Machado	M	60	CHIMERIX, INC.	10 anni
John A. MacPhee	M	56	ADAMAS PHARMACEUTICALS, INC.	8 anni
Jeffrey H. Knapp	M	58	ADAMAS PHARMACEUTICALS, INC.	2 anni
Lisa Ricciardi	F	64	CHIMERIX, INC.	-
Ernest Mario	M	85	CHIMERIX, INC.	-
Art Pappas	M	76	CHIMERIX, INC.	3 anni
Michael Bigham	M	66	ADAMAS PHARMACEUTICALS, INC.	5 anni
Ronald Renaud	M	55	CHIMERIX, INC.	6 anni
J. Enloe	M	60	Ajinomoto Althea, Inc. Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA.	7 anni
William Dawson	M	69	ADAMAS PHARMACEUTICALS, INC.	3 anni
R. Gordon Douglas	M	89	Vical, Inc. Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA.	20 anni
Ivan M. Lieberburg	M	74	ADAMAS PHARMACEUTICALS, INC.	16 anni
Jeffrey M. Nugent	M	76	Neothetics, Inc. Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA.	-
Dov Goldstein	M	56	ADMA BIOLOGICS, INC.	13 anni
Richard H. Booth	M	77	ADAMAS PHARMACEUTICALS, INC.	3 anni
Bill Ericson	M	65	ADAMAS PHARMACEUTICALS, INC.	16 anni
Spyridon Papapetropoulos	M	52	ADAMAS PHARMACEUTICALS, INC.	1 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	100	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni